Who is the manufacturer of extriCARE® 3000 Negative Wound Pressure Therapy System?

Alleva Medical Devices filed the 510(k) submission for extriCARE® 3000 Negative Wound Pressure Therapy System (K221223).

What is the FDA product code for extriCARE® 3000 Negative Wound Pressure Therapy System?

OMP. It is classified under 21 CFR 878.4780 as a Class 2 device in the General, Plastic Surgery panel.

What is the regulatory pathway for extriCARE® 3000 Negative Wound Pressure Therapy System?

510(k) clearance (submission type: Traditional).

Who can help prepare an FDA 510(k) submission like extriCARE® 3000 Negative Wound Pressure Therapy System?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

extriCARE® 3000 Negative Wound Pressure Therapy System

K221223 · Alleva Medical Devices · OMP · Feb 9, 2023 · General, Plastic Surgery

Device Facts

Record ID	K221223
Device Name	extriCARE® 3000 Negative Wound Pressure Therapy System
Applicant	Alleva Medical Devices
Product Code	OMP · General, Plastic Surgery
Decision Date	Feb 9, 2023
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 878.4780
Device Class	Class 2
Attributes	Therapeutic

Intended Use

The extriCARE® 3000 Negative Pressure Wound Therapy System is intended to generate negative pressure or suction to remove wound exudates, infectious material, and tissue debris from the wound bed. It is indicated for the following wound types: chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic or pressure), flaps and grafts. The extriCARE® 3000 Negative Pressure Wound Therapy System is intended for use in healthcare facilities.

Device Story

Portable, battery-powered NPWT pump; generates negative pressure to remove wound exudates, infectious material, and tissue debris. System includes pump and collection canisters (100cc/400cc). Used in healthcare facilities by clinicians. Vacuum delivered via airtight dressing; pressure monitored by internal sensor and proprietary algorithm. Touchscreen interface allows setting adjustments; sensors trigger alarms for blockages or leaks. Benefits patient by promoting wound healing through exudate removal and vacuum pressure application.

Clinical Evidence

Bench testing only. Performance verified via mechanical testing of key process parameters, electrical safety (IEC 60601-1), EMC (IEC 60601-1-2), package transportation (ISTA 3A), and usability/human factors testing. No clinical data presented.

Technological Characteristics

Portable, rechargeable battery-powered suction pump. Features touchscreen interface, pressure sensor, and alarm system for leakage/blockage. Compatible with extriCARE foam/bandage dressings. Electrical safety per IEC 60601-1:2005+AMD1:2012 and IEC 60601-1-11:2015. EMC per IEC 60601-1-2:2014. Non-sterile.

Indications for Use

Indicated for patients with chronic, acute, traumatic, subacute, dehisced wounds, partial-thickness burns, ulcers (diabetic/pressure), flaps, and grafts. Contraindicated for exposed vessels, organs, nerves, anastomotic sites, exposed arteries/veins, unexplored/non-enteric fistulas, untreated osteomyelitis, malignancy in wound, tissue with eschar, wounds too large/deep for dressing, patients unable to be followed by professionals, allergy to urethane dressings/adhesives, or use of topical products requiring frequent application.

Regulatory Classification

Identification

A powered suction pump is a portable, AC-powered or compressed air-powered device intended to be used to remove infectious materials from wounds or fluids from a patient's airway or respiratory support system. The device may be used during surgery in the operating room or at the patient's bedside. The device may include a microbial filter.

Predicate Devices

extriCARE 3600 Negative Pressure Wound Therapy System (K132225)

Reference Devices

extriCARE Foam Kit and Bandage Dressings (K140634)
extriCARE Foam Kit and Bandage Dressings (K110078)

Related Devices

K213906 — extriCARE 1000 Negative Pressure Wound Therapy System · Alleva Medical, Ltd. · Mar 8, 2023
K251646 — extriCARE® 1000 Negative Pressure Wound Therapy System · Alleva Medical Devices · Oct 3, 2025
K161599 — UNO Negative Pressure Wound Therapy System · Genadyne Biotechnologies, Inc. · Apr 6, 2017
K110078 — EXTRICARE · Devon Medical Products, Inc. · Feb 10, 2012
K180614 — PICO Single Use Negative Pressure Wound Therapy System · Smith & Nephew Medical Limited · Apr 6, 2018

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. February 9, 2023 Alleva Medical Devices % Mona Advani President, Regulatory Consultant Addwin Consulting Corporation 13260 Middleton Farm Ln Herndon, Virginia 20171 Re: K221223 Trade/Device Name: extriCARE® 3000 Negative Wound Pressure Therapy System Regulation Number: 21 CFR 878.4780 Regulation Name: Powered Suction Pump Regulatory Class: Class II Product Code: OMP Dated: January 10, 2023 Received: January 12, 2023 Dear Mona Advani: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. Julie A. Morabito -S Julie Morabito, Ph.D. Assistant Director DHT4B: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K221223 #### Device Name extriCARE®3000 Negative Pressure Wound Therapy System #### Indications for Use (Describe) The extriCARE® 3000 Negative Pressure Wound Therapy System is intended to generate negative pressure or suction to remove wound exudates, infectious material, and tissue debris from the wound bed. It is indicated for the following wound types: - chronic - · acute - · traumatic - subacute and dehisced wounds - · partial-thickness burns - · ulcers (such as diabetic or pressure) - · flaps and grafts. The extriCARE® 3000 Negative Pressure Wound Therapy System is intended for use in healthcare facilities. Type of Use (Select one or both, as applicable) | Prescription Use (Part 21 CFR 201 Subpart D) | On The Counter Use (21 CFR 201 Subpart C) | |----------------------------------------------|-------------------------------------------| |----------------------------------------------|-------------------------------------------| > Prescription Use (Part 21 CFR 801 Subpart D) | | Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ ## 510(k) Summary ## [as required by 21 CFR 807.92(c)] #### Alleva Medical Devices # extriCARE®3000 Negative Pressure Wound Therapy #### System K221223 | DATE PREPARED: | February 9, 2023 | |------------------------|----------------------------------------------------------------------------------------------------------------------------------| | APPLICANT | Alleva Medical Devices 1050 West Central Avenue, Unit B Brea, CA 92821 | | CONTACT | Mona Advani Regulatory Consultant Addwin Consulting Corporation Phone: 650-575-5819 Email: mona@addwinconsulting.com | | TRADE NAME: | extriCARE® 3000 Negative Pressure Wound Therapy System | | DEVICE CLASSIFICATION: | Class II per 21 CFR 878.4780 | | CLASSIFICATION NAME: | Powered Suction Pump | | PRODUCT CODE | OMP | | PREDICATE DEVICE: | extriCARE 3600 Negative Pressure Wound Therapy System (K132225) | #### INDICATION FOR USE: The extriCARE® 3000 Negative Pressure Wound Therapy System is intended to generate negative pressure or suction to remove wound exudates, infectious material, and tissue debris from the wound bed. It is indicated for the following wound types: - chronic - acute - traumatic ● - subacute and dehisced wounds - partial-thickness burns - ulcers (such as diabetic or pressure) ● - . flaps and grafts. The extriCARE® 3000 Negative Pressure Wound Therapy System is intended for use in healthcare facilities. {4}------------------------------------------------ ## DEVICE DESCRIPTION: The extriCARE 3000 Negative Pressure Wound Therapy (NPWT) pump is a portable, rechargeable, battery-powered pump intended to generate negative pressure or suction to remove wound exudates, infectious material, and tissue debris from the wound bed. The extriCARE 3000 Negative Pressure Wound Therapy (NPWT) is packaged and provided with the following components: - 1. extriCARE 3000 Negative Pressure Wound Therapy Pump - 2. extriCARE 3000 100cc Collection Canister The extriCARE® 3000 Negative Pressure Wound Therapy (NPWT) pump accessories that are included in this 510(k) application and will be commercialized separately are the following: - 1. extriCARE® 3000 100cc Collection Canister (additional canister replacements) - 2. extriCARE® 3000 400cc Collection Canister ### COMPARISON WITH PREDICATE DEVICE: The extriCARE® 3000 Negative Pressure Wound Therapy System shares the same technological principle with its predicate device, in which a vacuum is generated by a vacuum pump and delivered to the wound bed via airtight wound dressing to remove wound exudate and provide vacuum pressure on the wound bed. The vacuum pressure is applied for a specified period of time and intensity, according to the physician's prescription. The wound dressings used in this system are identical to those previously cleared under the predicate submissions. Similar to the predicates, vacuum is generated via a battery-powered miniature air pump. When the therapy begins, air and wound exudate are removed from the dressing underside (wound site) via the connection tubing to the collection canister until the target vacuum is reached. A pressure sensor inside the pump, along with a proprietary algorithm, monitors and controls the pressure on the wound site. Various user settings can be adjusted through the device touchscreen on the front. Other sensors are present to provide alarms if certain compromising issues, such as blockage or leakage, are encountered. See the table below for review of the comparison with the predicate device. {5}------------------------------------------------ | Item | Subject Device | Predicate Device | | |------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------| | Name | extriCARE ®3000 Negative Wound Therapy System | extriCARE 3600 Negative Pressure Wound Therapy System | | | Manufacturer | Alleva Medical Devices, LLC | Devon Medical Products | | | 510(k) Number | K221223 | K132225 | | | FDA Product Code | OMP | OMP | | | Regulation Number | 878.4780 | 878.4780 | | | Indication for Use | The extriCARE® 3000 NPWT System is intended to generate negative pressure or suction to remove wound exudates, infectious material, and tissue debris from the wound bed. It is indicated for the following wound types: chronic acute traumatic subacute and dehisced wounds partial-thickness burns ulcers (such as diabetic or pressure) flaps and grafts. The extriCARE® 3000 Negative Pressure Wound Therapy System is intended for use in healthcare facilities. | The extriCARE 3600 Negative Pressure Wound Therapy System is indicated for wound management via the application negative pressure to the wound by the removal of wound exudate, infectious materials, and tissue debris from the wound bed. The system is indicated for the following wound types: chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns ulcers (such as diabetic or pressure), and flaps and grafts | | | Contraindications | Exposed vessels, organs, or nerves. Anastomotic sites. Exposed arteries or veins in a wound. Fistulas, unexplored or non-enteric. Untreated osteomyelitis. Malignancy in the wound. | Exposed vessels, organs, or nerves. Anastomotic sites. Exposed arteries or veins in a wound. Fistulas, unexplored or non-enteric. Untreated osteomyelitis. Malignancy in the wound. | | | Item | Subject Device | Predicate Device | | | | tissue with eschar. Wounds which are too large or too deep to be accommodated by the dressing. Inability to be followed by a medical professional or to keep scheduled appointments. Allergy to urethane dressings and adhesives. Use of topical products which must be applied more frequently than the dressing change schedule allows | tissue with eschar. Wounds which are too large or too deep to be accommodated by the dressing. Inability to be followed by a medical professional or to keep scheduled appointments. Allergy to urethane dressings and adhesives. Use of topical products which must be applied more frequently than the dressing change schedule allows | | | Principle of Operation | A vacuum pump generates vacuum. A collection canister is connected to the vacuum pump, and a tubing connecting the wound dressing and the canister brings wound exudate | A vacuum pump generates vacuum. A collection canister is connected to the vacuum pump, and a tubing connecting the wound dressing and the canister brings wound exudate | | | Design | Vacuum mode | Continuous and intermittent | Continuous and intermittent | | | Intermittent mode | 5 minutes at target vacuum, then 2 minutes at 20mmHg | 5 minutes at target vacuum, then 2 minutes at 20mmHg | | | Collection canister sizes | 100cc and 400cc | 400cc and 1000cc | | Other Features | Prescription Use | Yes | Yes | | | Use Settings | Healthcare Facilities | Healthcare Facilities | | | Compatibility with extriCARE dressings | Compatible for use with extriCARE Foam Kit and Bandage Dressings, cleared under K140634 and K110078, | Compatible for use with extriCARE Foam Kit and Bandage Dressings, cleared under K140634 and K110078, | # Comparison Summary of the extriCARE 3000 NPWT System to the Predicate Device {6}------------------------------------------------ {7}------------------------------------------------ ## NON-CLINICAL TESTING / PERFORMANCE DATA: Non-clinical testing has been completed to demonstrate that the extriCARE 3000 NPWT System performs as intended and has performance characteristic that are substantially equivalent to or superior to the listed predicate device. The following is a summary of the testing that was performed or addressed in this submission. # Sterility The extriCARE 3000 and its predicate device are provided non-sterile. # Biocompatibility The extriCARE 3000 pump unit and collection canisters only have transient contact with the user. No additional biocompatibility testing was conducted on the pump and collection canisters. # Electrical Testing Electrical Testing was performed using the test standards IEC 60601-1:2005+AMD1:2012: Medical electrical equipment – Part 1: General requirements for safety and essential performance and IEC 60601-1-11:2015: Medical electrical equipment – Part 11: General requirements for basic safety and essential performance – Collateral Standard. Testing concluded that the Device met all test requirements for electrical safety. # EMC Evaluation Electromagnetic Compatibility (EMC) testing of the Device was performed using the test standard IEC 60601-1-2:2014: Medical electrical equipment – Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility -Requirements and tests. Testing concluded that the Device met all test requirements for EMC. ### Performance Testing-Bench Mechanical testing was performed to confirm the functionality of key process parameters were performed. All parameters tested were found to meet acceptance criteria established. ### Package Transportation Testing Transportation System Testing Packaging testing of extriCARE 3000 was conducted per the requirements of ISTA 3A. All tested parameters were found to meet acceptance criteria established. ### Usability Testing/Human Factors Testing Usability testing was performed to confirm that the intended user group was found to meet expected use goals. ### CONCLUSION: In accordance with the Federal Food, Drug and Cosmetic Act and 21 CFR Part 807, and based on the information provided in this pre-market notification, the manufacturer believes that the extriCARE 3000 NPWT Pump is substantially equivalent to the predicate device as described herein.